Pharmaceutical Contract Manufacturing

Summary

Global pharma industry faces numerous challenges in the form of increasing competition in generic markets, rising cost of new product development, declining research and development (R&D) productivity, shrinking average patent life, and mounting governmental pressure to reduce drug prices. Given the backdrop of such a competitive landscape, the decisive factors for growth and sustainability are faster new drug development and cost containment with Pharmaceutical Contract Manufacturing emerging as a strategic option offering several advantages. Firstly, outsourcing provides pharma companies the opportunity to avail flexibility, quicker time to market, and lower scale-up costs. Thus, companies will be able to meet growing demand for new drugs and focus on their core competencies. Secondly, outsourcing enables companies to reduce excess capacity in their manufacturing networks and restructure supply chains. Finally, value-added outsourcing services meet the increased demand for specialized manufacturing capabilities in key technical niches (such as lyophilization) and increased demand for back-up sources of supply.

These and other market data and trends are presented in "Pharmaceutical Contract Manufacturing: Global Market Trends" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Contents

• 1.Methodology
  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Quantitative Techniques & Reporting Level
• 2.Market Dynamics
  • An Insight into The Rise of Pcm
  • Industry Potential
• 3.Service Overview
  • Introduction
  • Injectables (Injections, Vials, and Iv Solutions)
  • Solid Dosage Forms (Sdfs) (Tablets and Capsules)
  • Liquid Dosage Forms (Ldfs) (Syrups and Suspensions)
  • A Focus on Bio-Manufacturing
• 4.Trends and Issues
  • Outsourcing Emerges as A Strategic Priority for Pharmaceutical Companies
  • Asia Dominates Regional Growth, North America Retains Position as Largest Market
  • Virtual Pharma vs. Blockbuster Model
  • Investment Risks in Pharmaceutical Contract
  • Quality Assurance Risk
  • Drug Development Risk
  • Acquisition Risk
  • Client Dependency Risk
• 5.Corporate Developments
  • Jubilant Acquires Draxis for US$ 253 Million
  • Jhp Acquires Assets of King Pharmaceuticals
  • Nextpharma Acquires Bioserv Corporation
  • Dr. Reddy's to Acquire Dowpharma's Facilities
  • Pharmathene to Acquire Avecia's Biodefense Vaccine Operations
  • Bioserv Enters into An Outsourcing Agreement with Biolife Solutions
  • Eden Biodesign and Stealthyx Therapeutics Ink An Agreement
  • Npil Pharma to Expand Hps Sites in Scotland
  • Dishman Pharma Installs New Api Facilities
  • Patheon Divests Niagara-Burlington Manufacturing Business to Pharmetics
  • Jubilant Organosys Acquires Hollister-Stier Laboratories
  • Hikma Pharmaceuticals Acquires Thymoorgan Gmbh Pharmazie
  • Meda Acquires Recip
  • Keata Pharma to Acquire Pfizer's Production Facility in Canada
  • Stada Acquires Makiz
  • Nextpharma to Expand Its Cytostatics Production Facility
  • Haupt Pharma Establishes Production Facility in Malta
• 6.Major Players
  • Althea Technologies (USA)
  • Catalent Pharma Solutions (USA)
  • Dishman Pharmaceuticals and Chemicals Ltd (India)
  • Haupt Pharma Ag (Germany)
  • Jubilant Organosys Ltd (India)
  • Kemwell Pvt. Ltd (India)
  • Nextpharma (UK)
  • Nipro Corp (Japan)
  • Patheon, Inc. (Canada)
  • Penn Pharmaceutical Services Ltd (UK)
  • Royal Dsm N.V. (Netherlands)
• 7.Market Analytics
• 8.The United States
  • Trends
  • Pharma Companies Increasingly Outsource Manufacturing Activity
  • Injectables Segment Witnesses Upward Growth Trend
  • Competitive Landscape
• 9.Canada
• 10.Japan
  • Impact of Contract Manufacturing on Japanese Pharmaceutical Sector
• 11.Europe
  • Trend
  • Injectables Segment Offers Promising Potential
  • Competitive Scenario
• 12.Asia-Pacific
  • Trends
  • Upbeat Market for Pharmaceutical Contract Manufacturing
  • Competitive Scenario
  • India
• 13.Rest of World
• Exhibits
  • Table 1: Global Markets for Pharmaceutical Contract Manufacturing by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 2: Percentage Breakdown of Global Markets for Pharmaceutical Contract Manufacturing by Region for The Years 2008 &
  • Table 3: Global Markets for Pharmaceutical Contract Manufacturing of Injectables by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 4: Percentage Breakdown of Global Markets for Pharmaceutical Contract Manufacturing of Injectables by Region for The Years 2008 &
  • Table 5: Global Markets for Pharmaceutical Contract Manufacturing of Solid Dosage Forms by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 6: Percentage Breakdown of Global Markets for Pharmaceutical Contract Manufacturing of Solid Dosage Forms by Region for The Years 2008 &
  • Table 7: Global Markets for Pharmaceutical Contract Manufacturing of Liquid Dosage Forms by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 8: Percentage Breakdown of Global Markets for Pharmaceutical Contract Manufacturing of Liquid Dosage Forms by Region for The Years 2008 &
  • Table 9: Pharmaceutical Contract Manufacturing Market by Product Segment in The US: 2007-2015 (Sales in US$ Million)
  • Table 10: Percentage Breakdown of Pharmaceutical Contract Manufacturing Market by Product Segment in The US for The Years 2008 &
  • Table 11: Pharmaceutical Contract Manufacturing Market by Product Segment in Canada: 2007-2015 (Sales in US$ Million)
  • Table 12: Percentage Breakdown of Pharmaceutical Contract Manufacturing Market by Product Segment in Canada for The Years 2008 &
  • Table 13: Pharmaceutical Contract Manufacturing Market by Product Segment in Japan: 2007-2015 (Sales in US$ Million)
  • Table 14: Percentage Breakdown of Pharmaceutical Contract Manufacturing Market by Product Segment in Japan for The Years 2008 &
  • Table 15: Pharmaceutical Contract Manufacturing Market by Product Segment in Europe: 2007-2015 (Sales in US$ Million)
  • Table 16: Percentage Breakdown of Pharmaceutical Contract Manufacturing Market by Product Segment in Europe for The Years 2008 &
  • Table 17: Pharmaceutical Contract Manufacturing Market by Product Segment in Asia-Pacific: 2007-2015 (Sales in US$ Million)
  • Table 18: Percentage Breakdown of Pharmaceutical Contract Manufacturing Market by Product Segment in Asia-Pacific for The Years 2008 &
  • Table 19: Pharmaceutical Contract Manufacturing Market by Product Segment in Rest of World: 2007-2015 (Sales in US$ Million)
  • Table 20: Percentage Breakdown of Pharmaceutical Contract Manufacturing Market by Product Segment in Rest of World for The Years 2008 &
• Companies Profiled